Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02263274 · ClinicalTrials.gov registry record · NA

Direct Cortical Measurement of the Intensity and Pattern of Current Flow Produced by TDCS

A NA study of Epilepsy, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT02263274 is a NA study of Epilepsy that has completed, run by NYU Langone Health. The registered enrollment target is 30 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02263274, a NA study of Epilepsy, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The primary study objective is to measure the electrical fields evoked by tDCS using subjects who have implanted intracranial electrodes as part of their evaluation for epilepsy surgery. The measurements obtained in these subjects and their brain MRI will be employed to validate existing mathematical models. In the future, these refined models can be used to target tDCS to predetermined brain regions in healthy and subjects and patient populations. As described above in the safety section, the intensities of stimulation applied in this project are not expected to produce changes in brain function, are below intensities commonly applied in clinical trials, and fall well below safety limits suggested by animal studies.

Conditions Studied

Interventions

  • DEVICE Transcranial Direct Current Stimulation (TDCS)

Study Locations (1)

New York

  • Neurology - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-11
Est. Completion 2026-01-09
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02263274

The ClinicalTrials.gov registry entry for NCT02263274 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (97% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Direct Current Stimulation (TDCS) is the first listed.

NCT02263274 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02263274 about?

NCT02263274 is a clinical study titled "Direct Cortical Measurement of the Intensity and Pattern of Current Flow Produced by TDCS". The primary study objective is to measure the electrical fields evoked by tDCS using subjects who have implanted intracranial electrodes as part of their evaluation for epilepsy surgery. The measurements obtained in these subjects and their brain MRI will be employed to validate existing mathematica...

What is the current status of trial NCT02263274?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-11. Estimated completion is 2026-01-09.

What conditions does trial NCT02263274 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT02263274?

The interventions under investigation include: Transcranial Direct Current Stimulation (TDCS) (DEVICE).

Who is sponsoring clinical trial NCT02263274?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02263274 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.